Advances in basic research on nephrology in 2021

doi:10.3877/cma.j.issn.2095-3216.2022.02.005

Abstract

Abstract:

In 2021, many important research advances have been made in the field of basic research on nephrology. This article focused on five topics: primary glomerular disease, secondary glomerular disease, acute kidney injury, renal fibrosis, and mineral and bone disorder, summarizing recent advances in the pathogenesis, biomarkers, and potential targets for new drugs, in order to provide new ideas for further basic research and clinical treatment of renal diseases.

Key words: Glomerular disease, Acute kidney injury, Renal fibrosis, Mineral and bone disorder

Simeng Liu, Si Chen, Meng Zhou, Qing Li, Lin Wu, Yanggang Yuan, Bo Zhang, Ningning Wang, Li Zhang, Huijuan Mao, Changying Xing. Advances in basic research on nephrology in 2021[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2022, 11(02): 79-83.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2022.02.005

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2022/V11/I02/79

References 39

[1]	Kalantar-Zadeh K, Jafar TH, Nitsch D, et al. Chronic kidney disease [J]. Lancet, 2021, 398(10302): 786-802.
[2]	Ronco P, Beck L, Debiec H, et al. Membranous nephropathy [J]. Nat Rev Dis Primers, 2021, 7(1): 69.
[3]	Sethi S, Madden B, Debiec H, et al. Protocadherin 7-associated membranous nephropathy [J]. J Am Soc Nephrol, 2021, 32(5): 1249-1261.
[4]	Al-Rabadi LF, Caza T, Trivin-Avillach C, et al. Serine protease HTRA1 as a novel target antigen in primary membranous nephropathy [J]. J Am Soc Nephrol, 2021, 32(7): 1666-1681.
[5]	Sethi S. New 'antigens’ in membranous nephropathy [J]. J Am Soc Nephrol, 2021, 32(2): 268-278.
[6]	Lomax-Browne HJ, Visconti A, Pusey CD, et al. IgA1 glycosylation is heritable in healthy twins [J]. J Am Soc Nephrol, 2017, 28(1): 64-68.
[7]	Wang YN, Zhou XJ, Chen P, et al. Interaction between GALNT12 and C1GALT1 associates with galactose-deficient IgA1 and IgA nephropathy [J]. J Am Soc Nephrol, 2021, 32(3): 545-552.
[8]	Farrar CA, Tran D, Li K, et al. Collectin-11 detects stress-induced L-fucose pattern to trigger renal epithelial injury [J]. J Clin Invest, 2016, 126(5): 1911-1925.
[9]	Allison SJ. Acute kidney injury: collectin-11: a signal for complement activation [J]. Nat Rev Nephrol, 2016, 12(7): 378.
[10]	Wei M, Guo WY, Xu BY, et al. Collectin11 and complement activation in IgA nephropathy [J]. Clin J Am Soc Nephrol, 2021, 16(12): 1840-1850.
[11]	Tang R, Meng T, Lin W, et al. A partial picture of the single-cell transcriptomics of human IgA nephropathy [J]. Front Immunol, 2021, 12: 645988.
[12]	Dotz V, Visconti A, Lomax-Browne HJ, et al. O- and N-glycosylation of serum immunoglobulin A is associated with IgA nephropathy and glomerular function [J]. J Am Soc Nephrol, 2021, 32(10): 2455-2465.
[13]	Xie D, Zhao H, Xu X, et al. Intensity of macrophage infiltration in glomeruli predicts response to immunosuppressive therapy in patients with IgA nephropathy [J]. J Am Soc Nephrol, 2021, 32(12): 3187-3196.
[14]	Han WK, Alinani A, Wu CL, et al. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma [J]. J Am Soc Nephrol, 2005, 16(4): 1126-1134.
[15]	Greenberg JH, Abraham AG, Xu Y, et al. Urine biomarkers of kidney tubule health, injury, and inflammation are associated with progression of CKD in children [J]. J Am Soc Nephrol, 2021, 32(10): 2664-2677.
[16]	Mori Y, Ajay AK, Chang JH, et al. KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease [J]. Cell Metab, 2021, 33(5): 1042-1061.
[17]	Doke T, Huang S, Qiu C, et al. Transcriptome-wide association analysis identifies DACH1 as a kidney disease risk gene that contributes to fibrosis [J]. J Clin Invest, 2021, 131(10): e141801.
[18]	Cao A, Li J, Asadi M, et al. DACH1 protects podocytes from experimental diabetic injury and modulates PTIP-H3K4Me3 activity [J]. J Clin Invest, 2021, 131(10): e141279.
[19]	Caza TN, Hassen SI, Kuperman M, et al. Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis [J]. Kidney Int, 2021, 100(1): 171-181.
[20]	Fava A, Rao DA, Mohan C, et al. Urine proteomics and renal single cell transcriptomics implicate IL-16 in lupus nephritis [J]. Arthritis Rheumatol, 2021, Epub ahead of print.
[21]	Amo L, Kole HK, Scott B, et al. CCL17-producing cDC2s are essential in end-stage lupus nephritis and averted by a parasitic infection [J]. J Clin Invest, 2021, 131(11): e148000.
[22]	Gan PY, Dick J, O'Sullivan KM, et al. Anti-CD20 mAb-induced B cell apoptosis generates T cell regulation of experimental myeloperoxidase ANCA-associated vasculitis [J]. J Am Soc Nephrol, 2021, 32(5): 1071-1083.
[23]	Moller-Hackbarth K, Dabaghie D, Charrin E, et al. Retinoic acid receptor responder1 promotes development of glomerular diseases via the nuclear factor-κB signaling pathway [J]. Kidney Int, 2021, 100(4): 809-823.
[24]	Moran SM, Scott J, Clarkson MR, et al. The clinical application of urine soluble CD163 in ANCA-associated vasculitis [J]. J Am Soc Nephrol, 2021, 32(11): 2920-2932.
[25]	Scholz H, Boivin FJ, Schmidt-Ott KM, et al. Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection [J]. Nat Rev Nephrol, 2021, 17(5): 335-349.
[26]	Tang C, Cai J, Yin XM, et al. Mitochondrial quality control in kidney injury and repair [J]. Nat Rev Nephrol, 2021, 17(5): 299-318.
[27]	Tonnus W, Meyer C, Steinebach C, et al. Dysfunction of the key ferroptosis-surveilling systems hypersensitizes mice to tubular necrosis during acute kidney injury [J]. Nat Commun, 2021, 12(1): 4402.
[28]	Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease [J]. Nat Rev Mol Cell Biol, 2021, 22(4): 266-282.
[29]	Zhu H, Cao C, Wu Z, et al. The probiotic L. casei Zhang slows the progression of acute and chronic kidney disease [J]. Cell Metab, 2021, 33(10): 2091-2093.
[30]	Radhakrishnan K, Kim YH, Jung YS, et al. Orphan nuclear receptor ERR-γ regulates hepatic FGF23 production in acute kidney injury [J]. Proc Natl Acad Sci USA, 2021, 118(16): e2022841118.
[31]	Li W, Wang C, Lv H, et al. A DNA nanoraft-based cytokine delivery platform for alleviation of acute kidney injury [J]. ACS Nano, 2021, Epub ahead of print.
[32]	Kim MG, Yun D, Kang CL, et al. Kidney VISTA prevents IFN-γ/IL-9 axis-mediated tubulointerstitial fibrosis after acute glomerular injury [J]. J Clin Invest, 2022, 132(1): e151189.
[33]	Sasaki K, Terker AS, Pan Y, et al. Deletion of myeloid interferon regulatory factor 4 (Irf4) in mouse model protects against kidney fibrosis after ischemic injury by decreased macrophage recruitment and activation [J]. J Am Soc Nephrol, 2021, 32(5): 1037-1052.
[34]	Peng F, Gong W, Li S, et al. circRNA_010383 acts as a sponge for miR-135a, and its downregulated expression contributes to renal fibrosis in diabetic nephropathy [J]. Diabetes, 2021, 70(2): 603-615.
[35]	van Zonneveld AJ, Kolling M, Bijkerk R, et al. Circular RNAs in kidney disease and cancer [J]. Nat Rev Nephrol, 2021, 17(12): 814-826.
[36]	Schmidt IM, Colona MR, Kestenbaum BR, et al. Cadherin-11, Sparc-related modular calcium binding protein-2, and pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis [J]. Kidney Int, 2021, 100(3): 672-683.
[37]	Yang L, Dai R, Wu H, et al. Unspliced XBP1 counteracts β-catenin to inhibit vascular calcification [J]. Circ Res, 2022, 130(2): 213-229.
[38]	Liu X, Chen A, Liang Q, et al. Spermidine inhibits vascular calcification in chronic kidney disease through modulation of SIRT1 signaling pathway [J]. Aging Cell, 2021, 20(6): e13377.
[39]	Chiu HW, Hou YC, Lu CL, et al. Cinacalcet improves bone parameters through regulation of osteoclast endoplasmic reticulum stress, autophagy, and apoptotic pathways in chronic kidney disease-mineral and bone disorder [J]. J Bone Miner Res, 2022, 37(2): 215-225.

Please choose a citation manager

Content to export